Ha Seojung, Lee Suji, Goo Bonhyuk, Kim Eunseok, Kwon Ojin, Nam Sang-Soo, Kim Joo-Hee
Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonju-si 26339, Republic of Korea.
Department of Acupuncture and Moxibustion, Kyung Hee University Medical Center, Seoul 02447, Republic of Korea.
Healthcare (Basel). 2024 Nov 29;12(23):2396. doi: 10.3390/healthcare12232396.
: Thread-embedding acupuncture (TEA) is widely used for cosmetic and therapeutic purposes; however, its safety profile, particularly in real-world clinical settings, remains under-researched. This study aimed to evaluate the safety profile of TEA through a prospective, observational analysis and confirm the feasibility of the study design for future studies involving larger patient populations. : A multicenter, prospective observational study was conducted involving 100 patients who received TEA. Adverse events (AEs) were tracked, including incidence, severity, and duration during the 6-month post-treatment period. Bivariate analysis was used to assess factors influencing AE occurrence, including treatment site, depth, and patient-specific variables. : A total of 100 patients received 136 treatments during the study period. A total of 12 AEs were reported, most of which were mild and transient local reactions, including pain and bruising. More than half of the AEs occurred on the day of the procedure, with an average duration of 7 days. No serious AEs were observed, and all events resolved without any lasting effects. Patients undergoing multiple treatments showed no significantly higher AE rates than those receiving a single session. : This study suggested that TEA generally has a favorable safety profile, with most AEs being mild and resolving without long-term effects. Further studies that evaluate the safety of TEA treatment across larger populations are recommended.
埋线针灸(TEA)广泛用于美容和治疗目的;然而,其安全性,尤其是在实际临床环境中的安全性,仍研究不足。本研究旨在通过前瞻性观察分析评估TEA的安全性,并确认该研究设计对未来涉及更大患者群体的研究的可行性。
开展了一项多中心前瞻性观察研究,纳入100例接受TEA治疗的患者。在治疗后6个月内追踪不良事件(AE),包括发生率、严重程度和持续时间。采用双变量分析评估影响AE发生的因素,包括治疗部位、深度和患者特定变量。
在研究期间,共有100例患者接受了136次治疗。共报告了12例AE,其中大多数为轻度和短暂的局部反应,包括疼痛和瘀伤。超过一半的AE发生在治疗当天,平均持续时间为7天。未观察到严重AE,所有事件均得到解决,无任何持久影响。接受多次治疗的患者AE发生率与接受单次治疗的患者相比无显著升高。
本研究表明,TEA总体上具有良好的安全性,大多数AE为轻度且无长期影响。建议进一步开展研究,评估更大人群中TEA治疗的安全性。